Table 1.
Subject and dataset information.
| Reference | Sample Size | Sex (M:F) | Mean Age (years) | Type (B:M) |
Size (mm) | Reference Standard |
|---|---|---|---|---|---|---|
| Hu et al. [48] | 1582 patients 1747 nodules | 567:1015 | 46.40 (SD: 9.65) | Thyroid 701:1046 |
14.51 ± 3.51 | FNA |
| Pereira et al. [49] | 165 patients 964 images | - | - | Thyroid 752:212 |
- | - |
| Qin et al. [50] | 233 patients 1156 nodules | - | - | Thyroid 539:617 |
- | Verified by clinical pathology |
| Săftoiu et al. [51] | 68 patients | 47:21 | Normal: 49.4 (SD: 15.4) ChPan: 55.1 (SD: 17.0) PanCA: 62.3 (SD: 12.9) |
Normal: 22 ChPan: 11 PanCA: 35 |
- | CT and biopsy |
| Săftoiu et al. [52] | 258 patients 774 recordings | 172:76 | PanCA: 64 (SD: 15.40) ChPan: 56 (SD: 13.25) |
Pancreatic 47:211 |
PanCA: 31.97 (SD: 11.69, 6–85) ChPan: 28.36 (SD: 12.23, 9–60) |
FNA biopsy, verified by clinical, biological exams, and repeated imaging tests |
| Sun et al. [53] | 245 patients 490 images | - | - | Thyroid 145:100 |
- | Biopsy |
| Udriștoiu et al. [54] | 65 patients 1300 images |
- | - | PDAC: 30 CPP: 20 PNET: 15 |
- | FNA biopsy |
| Zhang et al. [55] | 2032 patients 2064 nodules | 695:1337 | 45.25 (SD: 13.49) | Thyroid 1314:750 |
≤25 | - |
| Zhao et al. [56] | 174 patients 177 nodules | 45:132 | B: 47.9 M: 41.9 |
Thyroid 81:96 |
B: 23.4 M: 20.0 |
FNA biopsy |
| Zhao et al. [57] | 720 patients 743 nodules | 168:552 | 49.61 (15–89) | Thyroid 469:274 |
≥10 | Biopsy |
| Zhou et al. [58] | 70 patients 107 nodes | 10:60 | 30 | Thyroid 32:75 |
≤10 | FNA biopsy |
B:M: benign-to-malignant ratio; ChPan: chronic pancreatitis; CPP: chronic pseudotumoral pancreatitis; FNA: fine-needle aspiration; M:F: male-to-female ratio; PanCA: pancreatic cancer; PDAC: pancreatic ductal adenocarcinoma; PNET: pancreatic neuroendocrine tumor; SD: standard deviation.